Cargando…
164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
BACKGROUND: Complement-mediated acquired angioedema (AAE) is a rare condition characterized by an increased degradation of C1-esterase inhibitor (C1-INH) associated with lymphoproliferative disorders (AAE type I) or caused by autoantibodies against C1-INH (AAE type II). Reduced C1-INH activity leads...
Autores principales: | Siani, Maria Concetta, Petraroli, Angelica, Bova, Maria, Loffredo, Stefania, Triggiani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513162/ http://dx.doi.org/10.1097/01.WOX.0000411921.50578.c8 |
Ejemplares similares
-
165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
por: Bork, Konrad, et al.
Publicado: (2012) -
454 Efficacy of Icatibant Versus Fresh Frozen Plasma for Attacks of Hereditary Angioedema: Analysis of Indivudual Symptoms by Attack Site
por: Lara, Alicia, et al.
Publicado: (2012) -
87 Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
por: Lleonart, Ramon, et al.
Publicado: (2012) -
457 Clinical Features and Outcome of 82 Patients with Hereditary Angioedema
por: D'Ottaviano, Fabricio Loffredo, et al.
Publicado: (2012) -
586 Mucocutaneous Disease as a Presentation of Hereditary Angioedema. Report of 2 Cases
por: Alaniz, Angelica
Publicado: (2012)